Sulfonylureas Differ in Effects on Ischemic Preconditioning—Is it Time to Retire Glyburide?
- 1 February 2003
- journal article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 88 (2) , 528-530
- https://doi.org/10.1210/jc.2002-021971
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Myocardial K ATP Channels in PreconditioningCirculation Research, 2000
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Oral Sulfonylurea Hypoglycemic Agents Prevent Ischemic Preconditioning in Human MyocardiumCirculation, 1997
- Cardiovascular Effects of Conventional Sulfonylureas and GlimepirideHormone and Metabolic Research, 1996
- Mechanisms of the Glycaemic Effects of SulfonylureasHormone and Metabolic Research, 1996
- Ion Channel Effects of Antidiabetic SulfonylureasHormone and Metabolic Research, 1996
- Characterization of the Molecular Mode of Action of the Sulfonylurea, Glimepiride, at β-CellsHormone and Metabolic Research, 1996
- Cardiac ATP-sensitive K+ channels: regulation by intracellular nucleotides and K+ channel-opening drugsAmerican Journal of Physiology-Cell Physiology, 1995
- Does ischemic preconditioning occur in patients?Journal of the American College of Cardiology, 1994
- Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features.Circulation, 1990